ORPEA |
Market Closed -
Other stock markets
|
After market 02:25:58 pm | |||
| 12.25 EUR | -1.95% |
|
12.23 | -0.17% |
| 07:48am | ORPEA : Ready for a refoundation full of thorns |  |
| Apr. 17 | Emeis: EbitdaR target revised downwards for 2024 | CF |
| Sales 2023 | 5.2B 5.54B | Sales 2024 * | 5.44B 5.79B | Capitalization | 1.99B 2.12B |
|---|---|---|---|---|---|
| Net income 2023 * | -457M -487M | Net income 2024 * | -202M -215M | EV / Sales 2023 | 0.42 x |
| Net Debt 2023 * | 7.54B 8.03B | Net Debt 2024 * | 6.6B 7.03B | EV / Sales 2024 * | 1.58 x |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-0.01
x | Employees | 76,000 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 95.16% |
More Fundamentals
* Assessed data
More news
Latest transcript on ORPEA
More press releases
More news
| 1 day | -0.43% | ||
| 1 week | +13.84% | ||
| Current month | +22.71% | ||
| 1 month | +19.62% | ||
| 3 months | -7.16% | ||
| 6 months | -98.98% | ||
| Current year | -26.39% |
1 week
10.46
12.77
1 month
9.9714.40
Current year
9.9718.10
1 year
9.973 459.99
3 years
9.97111 100.00
5 years
9.97129 000.00
10 years
9.97129 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Laurent Guillot
CEO | Chief Executive Officer | 54 | 22-06-30 |
Laurent Lemaire
DFI | Director of Finance/CFO | - | 21-12-07 |
| Chief Tech/Sci/R&D Officer | - | 22-10-09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | 22-07-27 | |
Laurent Guillot
CEO | Chief Executive Officer | 54 | 22-06-30 |
Mireille Faugère
BRD | Director/Board Member | 66 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.13% | 18 M€ | +1.40% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 12.25 | -1.95% | 334 692 |
| 24-04-18 | 12.49 | +11.83% | 637,469 |
| 24-04-17 | 11.17 | 0.00% | 171,228 |
| 24-04-16 | 11.17 | +2.51% | 207,015 |
| 24-04-15 | 10.9 | -0.27% | 242,671 |
Real-time Euronext Paris, April 19, 2024 at 04:23 am EDT
More quotes
ORPEA is the European leader in global dependency care. The group operates retirement homes, follow-up care clinics, and psychiatric clinics.
At the end of 2022, ORPEA had a network of 992 facilities (90,860 beds) located in France (358 facilities; 33,462 beds), Benelux/the United Kingdom/Ireland (193 facilities; 10,708 beds), Central Europe (237 facilities; 23,765 beds), Eastern Europe (124 facilities; 12,764 beds), the Iberian Peninsula and Latin America (79 facilities; 10,007 beds) and China (1 facility; 154 beds)
The group has a real estate portfolio of nearly 2.3 million m2 with a value of EUR 6,500 million.
Net sales are distributed geographically as follows: France/Benelux/the United Kingdom/Ireland (59.9%), Central Europe (25.6%), Eastern Europe (9.3%), Iberian Peninsula and Latin America (5.1%) and other (0.1%).
Calendar
2024-05-13
- Q1 2024 Sales and Revenue Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
12.49
EUR
Average target price
10,975
EUR
Spread / Average Target
+87,742.16%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -26.39% | 2.12B | |
| -25.72% | 1.51B | |
| -4.84% | 1.35B | |
| +12.03% | 1.23B | |
| +11.31% | 679M | |
| -3.64% | 459M | |
| +206.52% | 370M | |
| -8.19% | 322M | |
| -8.53% | 115M | |
| +31.59% | 84.74M |
- Stock Market
- Equities
- ORP Stock
